Cytokine spectrum in patients with chronic hepatitis C in the treatment with interferon-alpha drugs

Terapevticheskii Arkhiv

Volumn 77, Issue 2, 2005, Pages 70-72

  Sobchak, D M ^a   Korochkina, O V ^a   Monakova, E A ^a  

^a NONE

Author keywords

Hepatitis; Interferon; Interleukin; Intron; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; AMINOTRANSFERASE; AUTACOID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; RECOMBINANT ALPHA2B INTERFERON; RNA; VIRUS RNA;

ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; IMMUNE RESPONSE; MALE; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERLEUKIN-4; INTRONS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 17144386580     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Fan X. G., Lui W. E. et al. Circulating Th1 and Th2 cytokines in patients with hepatitis virus infection. Mediators Inflamm. 1998; 7(4): 295-297.
2. Hung Y. S., Hwang S. J. et al. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Chin. Med. J. 1999; 2(6): 327-333.
3. Hultgen C., Milich D. R. et al. The antiviral compound ribavirin modulates the Th1/Th2 subset balance in hepatitis B and C virus -specific immune responses. J. Gen. Virol. 1998; 79(10): 2381-2891.